Crossmark

Enhancing the understanding and management of metabolic dysfunction-associated steatotic liver disease in colorectal cancer patients: insights and future directions

Crossref DOI link: https://doi.org/10.1007/s12072-025-10947-8

Published Online: 2025-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Zhexian

Li, Na https://orcid.org/0009-0005-1648-9095
License Information

Text and Data Mining valid from 2025-10-29

Version of Record valid from 2025-10-29
More Information

Article History

Received: 24 September 2025

Accepted: 17 October 2025

First Online: 29 October 2025

Declarations

:

: Zhexian Liu and Na Li declare no competing financial interests.

: Not applicable.

Document is current

Any future updates will be listed below